Fernanda Zamboni

Dr Fernanda Zamboni is a postdoctoral research fellow at Queensland University of Technology (QUT), affiliated with the Centre for Biomedical Technologies and the Translational Research Institute (TRI). She holds a PhD in Biomedical Engineering from the University of Limerick (2021), where she was supported by the Irish Research Council Postgraduate Scholarship and an ERASMUS+ Traineeship grant. Her postdoctoral research (2021–2023) included collaboration with the Chinese University of Hong Kong. Dr Zamboni specializes in biomaterials, tissue engineering, and immunomodulation, with a focus on hyaluronic acid-based composites and antimicrobial polymers. She has authored 19 research articles and 4 book chapters, accumulating over 600 citations and a H-index of 14. Her work has been recognized with 2 conference prizes and 39 abstract presentations.

Education:

• Pharmacy (Federal University of Rio Grande do Sul)
• M.Sc. Biomedical Device Materials (University of Limerick, First-Class Honours)
• PhD in Biomedical Engineering (University of Limerick)

Research Interests:

• Biomaterials for regenerative medicine
• Antimicrobial surface engineering
• Hyaluronic acid applications in immunomodulation
• 3D bioprinting and scaffold design

Her recent studies explore hydrothermal processing of carrageenan for tissue engineering and electrical stimulation in musculoskeletal regeneration. She also investigates curcumin-loaded bioinks for in situ immunoregulation.

Scientific Awards:

• Irish Research Council Postdoctoral Fellowship (2021–2023)
• Government of Ireland International Education Scholarship
• First-Class Honours (M.Sc.)

Teaching & Collaboration:

• Principal Lecturer: Biopolymers Science at University of Limerick
• Guest lectures on Biocompatibility, Cell Culture, and Immunomodulation
• Collaborations with I3B Research Group (University of Minho) and Prince of Wales Hospital (Hong Kong)

Labs & Affiliations: Active in the Centre for Biomedical Technologies (QUT) and TRI, focusing on translational biomedical research.